v3.26.3
Stockholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 23, 2026
Dec. 29, 2025
Jul. 25, 2025
May 23, 2025
May 12, 2025
May 15, 2024
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Jul. 28, 2026
Dec. 31, 2025
Mar. 31, 2026
Jul. 28, 2025
Jul. 24, 2025
Jul. 11, 2025
Jul. 10, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Value of shares available for sale           $ 75,000,000                      
Stock issued during period, value, new issues             $ 451,932 $ 3,472,820 $ 1,294,636 $ 6,436,547              
Reverse stock split     15-for-1 reverse stock split                            
Reverse stock split conversion     each 15 shares of issued and outstanding common stock and equivalents were consolidated into one share of common stock.                            
Share price     $ 1.00                            
Common stock, shares outstanding     2,121,942       6,210,956   6,210,956     3,419,650     31,828,447    
Options outstanding     100,000                       1,900,000    
Common stock issuable upon exercise     800,000                     1,000,000.0 12,700,000    
Common stock, shares authorized             350,000,000   350,000,000     350,000,000       350,000,000 112,500,000
Dividend percentage                           15.00%      
Dividend price per share                     $ 0.15            
Proceeds from sale of stock                 $ 1,292,932 $ 6,437,251              
Common stock par value             $ 0.01   $ 0.01     $ 0.01          
Value of shares for compensation and fees             $ 509,772   $ 965,123                
Officers and Director [Member[                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Number of shares for compensation and fees                 157,088                
Value of shares for compensation and fees                 $ 278,119                
May 2025 Warrant Exchange [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Common stock issuable upon exercise         333,334                        
Common stock par value         $ 0.01                        
Shares issued upon exercise of warrants         194,734                        
Common stock outstanding percentage         19.98%                        
Minimum [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Public float value                         $ 75,000,000        
At the Market Offering Agreement [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Value of shares available for sale $ 7,000,000                                
Number of shares sold                 625,480 744,646              
Proceeds from sale of stock                 $ 1,292,922 $ 4,530,663              
Proceeds from sale of stock remained                   10,806,593              
Securities Purchase Agreement [Member] | May 2025 Offering [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Number of shares issued       185,186                          
Gross proceeds from offering       $ 3,300,000                          
Securities Purchase Agreement [Member] | December 2025 Offering [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Number of shares issued   330,000                              
Gross proceeds from offering   $ 7,000,000.0                              
Common Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued during period, value, new issues             $ 2,685 $ 5,433 $ 6,255 $ 10,328              
Sale of stock, consideration received on transaction                       $ 10,000,000          
Shares issued upon exercise of warrants               10,767   10,767              
Number of shares issued             268,504 543,265 625,480 1,032,752              
Number of shares for compensation and fees             303,792   556,712                
Value of shares for compensation and fees             $ 3,038   $ 5,567                
Common Stock [Member] | At the Market Offering Agreement [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued during period, value, new issues $ 7,000,000                                
Pre-funded Warrants [Member] | Securities Purchase Agreement [Member] | May 2025 Offering [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Warrants issued to purchase common stock       296,297                          
Warrants exercise price       $ 0.0001                          
Pre-funded Warrants [Member] | Securities Purchase Agreement [Member] | December 2025 Offering [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Warrants issued to purchase common stock   1,609,114                              
Warrants exercise price   $ 0.0001                              
Warrant [Member] | Securities Purchase Agreement [Member] | May 2025 Offering [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Warrants issued to purchase common stock       962,964                          
Warrants exercise price       $ 6.75                          
Warrant [Member] | Securities Purchase Agreement [Member] | December 2025 Offering [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Warrants issued to purchase common stock   1,939,114                              
Warrants exercise price   $ 3.482                              
Warrants exercisable condition   The Company cannot effect the exercise of any December 2025 Pre-funded Warrant or December 2025 Warrant, and a holder will not be entitled to exercise any portion of any December 2025 Pre-funded Warrant or December 2025 Warrant, if, upon giving effect to such exercise, the aggregate number of shares of Common Stock beneficially owned by the holder (together with its affiliates) would exceed 9.99% or 4.99%, respectively, of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, which percentage may be increased or decreased at the holder’s election upon 61 days’ notice to the Company subject to the terms of such December 2025 Pre-funded Warrants or December 2025 Warrants, provided that such percentage may in no event exceed 19.99%.                              
Placement Agents Warrant [Member] | Securities Purchase Agreement [Member] | May 2025 Offering [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Warrants issued to purchase common stock       24,075                          
Warrants exercise price       $ 8.44                          
Prefunded Warrant and Warrants [Member] | Securities Purchase Agreement [Member] | December 2025 Offering [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Share price   $ 3.6099